Identifying translocations in solid tumors: Webinar by Brady Culver, PhD

Developing and characterizing a comprehensive NGS panel to assess gene fusions in carcinomas

Brady Culver, PhD, Director of NGS Products and Instrumentation at ArcherDX, describes the challenges of gene fusions discovery in solid tumors and his process for developing and characterizing a comprehensive NGS panel to assess translocations in these tumor types.

Topics that Dr. Culver discusses include:

  • The role of gene fusions in solid tumors
  • Selecting gene targets for an NGS-based fusion panel
  • Assessing panel performance and rebalancing probes
  • Data gathered from the panel
  • Recommendations for panel use

The webinar was recorded on Wednesday, April 15, 2015.

 

About Brady Culver, PhD


Brady Culver, PhD, R&D Lead Manager/Scientist, ArcherDX, Inc.

Dr. Culver, Director of NGS Products and Instrumentation at ArcherDX, Inc., and earned his Doctoral degree from UC Boulder studying centriolar protein homologs in Tetrahymena thermophila before researching sub-cellular compartmentalization and protein-protein interactions of mutant Huntington's disease protein as a Post-doctoral fellow at NYU School of medicine. Dr. Culver's years in functional genomics research have placed him as the lead inventor on several provisional patents for novel gene modulation methods and empowered his solid-tumor focused research at ArcherDX. When not in the lab, Dr. Culver can be found on the local ski slopes or mountain biking.

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.